ValuEngine Lowers Encision Inc. (ECIA) to Sell

ValuEngine cut shares of Encision Inc. (OTCMKTS:ECIA) from a hold rating to a sell rating in a research note released on Friday.

Shares of Encision (OTCMKTS ECIA) opened at 0.40 on Friday. The company’s market capitalization is $4.27 million. Encision has a one year low of $0.18 and a one year high of $0.52. The company’s 50-day moving average price is $0.42 and its 200-day moving average price is $0.40.

Encision (OTCMKTS:ECIA) last issued its earnings results on Thursday, July 27th. The medical device company reported $0.02 EPS for the quarter. Encision had a negative return on equity of 22.86% and a negative net margin of 5.00%. The business had revenue of $2.36 million for the quarter.

TRADEMARK VIOLATION NOTICE: This story was originally posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this story on another publication, it was copied illegally and republished in violation of U.S. and international copyright laws. The legal version of this story can be viewed at https://ledgergazette.com/2017/10/10/valuengine-lowers-encision-inc-ecia-to-sell.html.

Encision Company Profile

Encision Inc is a medical device company. The Company designs, develops, manufactures and markets surgical instruments that provide safety to patients undergoing minimally-invasive surgery. Its Active Electrode Monitoring (AEM) technology provides surgeons with the desired tissue effects of cutting and coagulating tissue in laparoscopic procedures, while preventing stray electrosurgical energy that can cause comp

Shares of Encision (OTCMKTS ECIA) opened at 0.40 on Friday. The company’s market capitalization is $4.27 million. Encision has a one year low of $0.18 and a one year high of $0.52. The company’s 50-day moving average price is $0.42 and its 200-day moving average price is $0.40.

Encision (OTCMKTS:ECIA) last issued its earnings results on Thursday, July 27th. The medical device company reported $0.02 EPS for the quarter. Encision had a negative return on equity of 22.86% and a negative net margin of 5.00%. The business had revenue of $2.36 million for the quarter.

TRADEMARK VIOLATION NOTICE: This story was originally posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this story on another publication, it was copied illegally and republished in violation of U.S. and international copyright laws. The legal version of this story can be viewed at https://ledgergazette.com/2017/10/10/valuengine-lowers-encision-inc-ecia-to-sell.html.

Encision Company Profile

Encision Inc is a medical device company. The Company designs, develops, manufactures and markets surgical instruments that provide safety to patients undergoing minimally-invasive surgery. Its Active Electrode Monitoring (AEM) technology provides surgeons with the desired tissue effects of cutting and coagulating tissue in laparoscopic procedures, while preventing stray electrosurgical energy that can cause complications and even death.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Encision Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encision Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply